Drs Kevin Alexander and Joban Vaishnav explore when and how to use genetic testing in ATTR-CM, why distinguishing hereditary from wild-type disease matters, and what this means for patients' families.
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...
Wave Life Sciences shares plunged >50% after Phase 1 INLIGHT data for WVE-007 showed <1% placebo-adjusted weight loss at six ...
Delivered record net revenue of $59.5 million for 2025 (22% increase from 2024) and record quarterly net revenue of $16.5 million in Q4 2025 (up ...
Q4 2025 Earnings Call March 24, 2026 5:00 PM EDTCompany ParticipantsKyle Kazan - Co-founder, Chairman & CEOMark ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the ...
A powerful new real-world data platform could transform how scientists predict and understand Alzheimer's disease and ...
Stronger, more stable core, loading.
A new study reveals all five fundamental nucleobases—the molecular "letters" of life—have been detected in samples from the ...
An international research collaboration led by Queen Mary University of London and University of the Witwatersrand (Wits) in ...
Scientists at Cincinnati Children's have identified how certain immune cells are molecularly programmed to respond faster ...
Notice hair thinning or loss? Hers hair growth products might be able to help. Here's a break down of its cost, effectiveness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results